Which Patients Benefit Most from Immunotherapy?
Harnessing the body’s immune system to treat cancer has made remarkable cures possible — but not for every patient. Researchers from UConn Health and the Cleveland Clinic...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Harnessing the body’s immune system to treat cancer has made remarkable cures possible — but not for every patient. Researchers from UConn Health and the Cleveland Clinic...
New Haven, Conn., December 14, 2021 – Jonathan Rothberg, Ph.D., a serial entrepreneur who founded 4Catalyzer and has founded and led a number of other Connecticut bioscience initiatives, has...
The Connecticut Academy of Science and Engineering has elected Dawn Hocevar, President and Chief Executive Officer of BioCT, an Honorary Member of the Academy. The Academy’s Governing...
Thetis Pharmaceuticals reports that Dr. Chris Takimoto has joined its Scientific Advisory Board. Dr. Takimoto joins the Thetis SAB with 30 years of experience in cancer...
Digital Currency Group, an investor in bitcoin and blockchain technology companies, is moving its headquarters from New York City to Stamford. The company is set...
Biohaven Pharmaceuticals will seek FDA approval of a new fast-acting nasal spray for migraine, after the drug soared through a Phase 3 clinical trial. The drug,...
A small drug development company that moved its headquarters last year from Cambridge, MA to the BioCT Innovations Commons on Shennecossett Road in Groton, is aiming to...
In just three years, Farmington-based medical device company CytoVeris has gone from a small startup with the goal of helping surgeons better detect cancer, to a company...
Rallybio reports data from its ongoing Phase 1b study of RLYB211 showing significant benefit over placebo. RLYB211, a plasma-derived polyclonal anti-HPA-1a antibody, is being evaluated...
Connecticut area bioscience companies have joined forces to launch an internship program with a goal of developing and attracting new talent. The new program, dubbed...